December 18th, 2011 by John Mandrola, M.D. in Research
4 Comments »
Dear Endurance Athletes,
Accept an apology in advance. You have endured so much from me.
Sorry.
Let’s at least start by agreeing that I can’t control the data.
Yes, you guessed it. There is unfortunately more bad news pertaining to the deleterious effects of endurance exercise on the human heart.
Again, I am sorry. Maybe re-phrasing the previous sentence will soften the blow. How about this: “Yet another study on endurance athletes suggests that exercise, like everything else in life, has an upper limit.”
Here goes, buckle up. Read more »
*This blog post was originally published at Dr John M*
December 15th, 2011 by DeborahSchwarzRPA in News
No Comments »
Yoshifumi Naka, MD, PhD
Total Artificial Heart Improves Patient Survival to Transplant While Reducing Some Risks of Transplant Surgery
Surgeons at NewYork-Presbyterian Hospital/Columbia University Medical Center performed the first Total Artificial Heart implant in the New York City area to replace a patient’s dying heart.
“For patients who will die without a heart transplant, the Total Artificial Heart helps them survive until they can get one. By replacing the heart, we are eliminating the symptoms and the source of heart failure,” said lead surgeon Dr. Yoshifumi Naka, director of Cardiac Transplantation and Mechanical Circulatory Support Programs at New York-Presbyterian/Columbia and associate professor of surgery at Columbia University College of Physicians and Surgeons.
Similar to a heart transplant, the SynCardia temporary Total Artificial Heart Read more »
*This blog post was originally published at Columbia University Department of Surgery Blog*
December 9th, 2011 by HarvardHealth in Health Tips, Research
No Comments »
These days, most adults are overweight, not active, or both. If you could change just one—become active or lose weight—which would be better?
At least for men, being more fit may have a bigger health payoff than losing weight, according to a new study of more than 14,000 well-off middle-aged men who are participating in the Aerobics Center Longitudinal Study. Researchers followed their health, weight, and exercise habits for 11 years. They estimated how physically fit the men were by calculating their metabolic equivalents (METs) from a treadmill test.
Compared with men whose fitness declined over the course of the study, those who maintained their fitness levels reduced their odds of dying from cardiovascular disease or any other cause by about 30%, even if they didn’t lose any excess weight. Those who improved their fitness levels saw a 40% reduction.
Body-mass index (BMI), a measurement that takes weight and height into account, was not associated with mortality. The results were published in the journal Circulation.
What is “fitness”
Fitness is a measure of Read more »
*This blog post was originally published at Harvard Health Blog*
December 6th, 2011 by iMedicalApps in News
1 Comment »
A recent report by ABI Research, providing a broad overview of the mHealth industry, predicts extraordinary grown in health and fitness apps over the next five years.
The report, Mobile Devices and mHealth, includes forecasts for the next five years on factors such as regional smartphone adoption rates, app downloads, and wearable device usage among others. One major conclusion from the report is that the sports and health mobile application market will grow to over $400 million in 2016 – up from just $120 million in 2010.
Mobile health devices recently received a major boost with the incorporation of Bluetooth 4.0, which is expected to spur the development and launch of devices that will take advantage of the lower energy consumption. While much interest is focused on blood glucose monitors, remote monitoring of cardiac rhythms, and other similar parameters, one conclusion of this report is that some of the most impressive growth will be in health and fitness apps that are more directly consumer-oriented.
The report itself, for a rather hefty price, also addresses other questions like Read more »
*This blog post was originally published at iMedicalApps*
December 6th, 2011 by DrWes in Opinion
3 Comments »
Several days ago, the world’s leading cholesterol-lowering “statin” drug, Lipitor, went generic. Doctors are bearing the brunt of the conversion with little information about what the new drug will cost for their patients.
This, of course, is the plan.
Even the Wall Street Journal which has an excellent “user’s guide” to making the switch from name-brand to generic Lipitor offers little help as it mentions “co-pays” rather than actual drug cost:
How much cheaper will generic Lipitor be?
Insurance copayments should drop considerably, if patients are getting Lipitor or atorvastatin on the generic tier of their health plans. Currently, Lipitor has been on a higher, branded tier for prescription drugs. Copays for branded drugs average either $29 or $49 depending on the tier, according to Kaiser Family Foundation. Copays for generics average $10.
In addition, Ranbaxy Laboratories Ltd, one of the generic manufacturers of generic Lipitor, won concessions to maintain elevated prices for 180 days from the government (a la our own Food and Drug Administration while the Federal Trade Commission stands idly by complaining how consumers are gouged with this arrangement) to assure prices stay high a bit longer.
But if we forget the insurers and copays, how much will the generic drug actually cost consumers? Read more »
